Skip to Main Content

Advertisement

Skip Nav Destination

Featured Content

Lymphohematopoietic Clones: Are They of Unknown Significance, Indeterminate Potential, or Indeterminate Progression?

Dr. Marshall Lichtman looks at the history and direction of the classification of lymphohematopoietic clones.

Treatment and Prevention of Venous Thromboembolism in Children: Current State and Future Directions

Drs. Marisol Betensky, John Morrison, Anthony Sochet, and Neil Goldenberg review the treatment and prevention of venous thromboembolism in pediatric patients.

FEDORA: The Beginning of a Beautiful Friendship?

Drs. Bethan Psaila and Mary Frances McMullin provide commentary on a study evaluating the tolerability, safety, and activity of fedratinib combined with ropeginterferon alfa-2β in patients with myelofibrosis.

Close Modal

or Create an Account

Close Modal
Close Modal